FDA grants two key designations to Passage Bio's experimental Krabbe disease therapy

One of the designations could result in the Philadelphia company receiving a potentially lucrative voucher from the federal agency.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.